Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001415889-22-001224

EVP, CHIEF SCIENTIFIC OFFICER acquired 31,709 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER 2022-02-10 Grant or award +31,709 73,494 D
Derivatives
Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER 2022-02-10 Grant or award · Stock Option (right to buy) +93,398 93,398 D
Loading xslF345X03/form4-02112022_010249.xml…